BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20483788)

  • 1. Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function.
    Sabeh F; Fox D; Weiss SJ
    J Immunol; 2010 Jun; 184(11):6396-406. PubMed ID: 20483788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
    Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
    Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts.
    Rutkauskaite E; Volkmer D; Shigeyama Y; Schedel J; Pap G; Müller-Ladner U; Meinecke I; Alexander D; Gay RE; Drynda S; Neumann W; Michel BA; Aicher WK; Gay S; Pap T
    Arthritis Rheum; 2005 Jul; 52(7):2010-4. PubMed ID: 15986375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.
    García-Vicuña R; Gómez-Gaviro MV; Domínguez-Luis MJ; Pec MK; González-Alvaro I; Alvaro-Gracia JM; Díaz-González F
    Arthritis Rheum; 2004 Dec; 50(12):3866-77. PubMed ID: 15593223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of membrane-type 1 MMP in human rheumatoid synovium tissues.
    Qin S; Wang F; Zhou M; Ding W; Chen L; Lu Y
    Int J Clin Exp Pathol; 2015; 8(8):9286-92. PubMed ID: 26464678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses.
    Niarakis A; Giannopoulou E; Ravazoula P; Panagiotopoulos E; Zarkadis IK; Aletras AJ
    FEBS J; 2013 Dec; 280(24):6541-55. PubMed ID: 24112707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.
    Miller MC; Manning HB; Jain A; Troeberg L; Dudhia J; Essex D; Sandison A; Seiki M; Nanchahal J; Nagase H; Itoh Y
    Arthritis Rheum; 2009 Mar; 60(3):686-97. PubMed ID: 19248098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IV collagen alpha-chain composition in synovial lining from trauma patients and patients with rheumatoid arthritis.
    Poduval P; Sillat T; Beklen A; Kouri VP; Virtanen I; Konttinen YT
    Arthritis Rheum; 2007 Dec; 56(12):3959-67. PubMed ID: 18050191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis.
    Khalkhali-Ellis Z; Seftor EA; Nieva DR; Handa RJ; Price RH; Kirschmann DA; Baragi VM; Sharma RV; Bhalla RC; Moore TL; Hendrix MJ
    J Rheumatol; 2000 Jul; 27(7):1622-31. PubMed ID: 10914842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis.
    Pap T; Shigeyama Y; Kuchen S; Fernihough JK; Simmen B; Gay RE; Billingham M; Gay S
    Arthritis Rheum; 2000 Jun; 43(6):1226-32. PubMed ID: 10857781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lipid peroxide on production of matrix metalloproteinase 1 (tissue collagenase) and 3 (stromelysin) and tissue inhibitor metalloproteinase 1 by human rheumatoid synovial fibroblasts.
    Hiraoka K; Sasaguri Y; Komiya S; Zenmyo M; Inoue A; Morimatsu M
    Exp Mol Pathol; 1993 Dec; 59(3):169-76. PubMed ID: 8137899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes.
    Ahn JK; Koh EM; Cha HS; Lee YS; Kim J; Bae EK; Ahn KS
    Rheumatology (Oxford); 2008 Jun; 47(6):834-9. PubMed ID: 18400834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription.
    Mix KS; McMahon K; McMorrow JP; Walkenhorst DE; Smyth AM; Petrella BL; Gogarty M; Fearon U; Veale D; Attur MG; Abramson SB; Murphy EP
    Arthritis Rheum; 2012 Jul; 64(7):2126-36. PubMed ID: 22275273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
    van Lent PL; Span PN; Sloetjes AW; Radstake TR; van Lieshout AW; Heuvel JJ; Sweep CG; van den Berg WB
    Ann Rheum Dis; 2005 Mar; 64(3):368-74. PubMed ID: 15485996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease.
    Qu Z; Huang XN; Ahmadi P; Andresevic J; Planck SR; Hart CE; Rosenbaum JT
    Lab Invest; 1995 Sep; 73(3):339-46. PubMed ID: 7564266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis.
    Chabaud M; Garnero P; Dayer JM; Guerne PA; Fossiez F; Miossec P
    Cytokine; 2000 Jul; 12(7):1092-9. PubMed ID: 10880256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.
    O'Hara R; Murphy EP; Whitehead AS; FitzGerald O; Bresnihan B
    Arthritis Rheum; 2004 Jun; 50(6):1788-99. PubMed ID: 15188355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
    Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.